Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: A mechanism for virulence activation in the cystic fibrosis lung

Microbiology

Volumn 145, Issue 6, 1999, Pages 1349-1357

  Mathee, Kalai ^a   Ciofu, Oana ^d   Sternberg, Claus ^b   Lindum, Peter W ^b   Campbell, Joan I A ^d   Jensen, Per ^c   Johnsen, Anders H ^c   Givskov, Michael ^b   Ohman, Dennis E ^a   Molin, Søren ^b   Høiby, Niels ^c   Kharazmi, Arsalan ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c University of Copenhagen   (Denmark)

^d NONE

Author keywords

Alginate; Biofilm; Cystic fibrosis; Oxygen radicals; PMN; Pseudomonas aeruginosa

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE; ELASTASE; HYDROGEN PEROXIDE; OXYGEN RADICAL;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BIOFILM; CYSTIC FIBROSIS; GENE ACTIVATION; GROWTH RATE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS); MAMMALIA; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0033056054     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/13500872-145-6-1349     Document Type: Article

References (54)

1. Baltimore, R. S., Christie, C. D. & Smith, G. J. (1989). Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 140, 1650-1661.
2. Berry, A., DeVault, J. D. & Chakrabarty, A. M. (1989). High osmolarity is a signal for enhanced algD transcription in mucoid and nonmucoid Pseudomonas aeruginosa strains. J Bacteriol 171, 2312-2317.
3. Boucher, J. C., Yu, H., Mudd, M. H. & Deretic, V. (1997). Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65, 3838-3846.
4. Boyer, H. W. & Roullard-Dussoix, D. (1969). A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol 41, 459-472.
5. Brown, R. K., McBumey, A., Lunec, J. & Kelly, F. J. (1995). Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med 18, 801-806.
6. Campbell, J., Ciofu, O. & Høiby, N. (1997). Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different β-lactamase expression phenotypes but are homogeneous in the ampC-ampR. genetic region. Antimicrob Agents Chemother 41, 1380-1384.
7. Christensen, B. B., Sternberg, C., Andersen, J. B., Eberl, L., Moller, S., Givskov, M. & Molin, S. (1998). Establishment of new genetic traits in a microbial biofilm community. Appl Environ Microbiol 64, 2247-2255.
8. Chu, L., May, T. B., Chakrabarty, A. M. & Misra, T. K. (1991). Nucleotide sequence and expression of the algE gene involved in alginate biosynthesis by Pseudomonas aeruginosa. Gene 107, 1-10.
9. DeVault, J. D., Kimbara, K. & Chakrabarty, A. M. (1990). Pulmonary dehydration and infection in cystic fibrosis: evidence that ethanol activates gene expression and induction of mucoidy in Pseudomonas aeruginosa. Mol Microbiol 4, 737-745.
10. DeVries, C. A. & Ohman, D. E. (1994). Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternative sigma factor, and shows evidence for autoregulation. J Bacteriol 176, 6677-6687.
11. Evans, L. R. & Linker, A. (1973). Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa. J Bacteriol 116, 915-924.
12. Figurski, D. & Helinski, D. R. (1979). Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci USA 76, 1648-1652.
13. Filip, C., Fletcher, G., Wulff, J. L. & Earhart, C. F. (1973). Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J. Bacteriol 115, 717-722.
14. Frederiksen, B., Koch, C. & Høiby, N. (1997). Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 23, 330-335.
15. Giwercman, B., Jensen, E. T., Høiby, N., Kharazmi, A. & Costerton, J. W. (1991). Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob Agents Chemother 35, 1008-1010.
16. Goldberg, J. B. & Ohman, D. E. (1987). Construction and characterization of Pseudomonas aeruginosa algB mutants: role of algB in high-level production of alginate. J Bacteriol 169, 1593-1602.
17. Govan, J. R. & Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539-574.
18. Grabert, E., Wingender, J. & Winkler, U. K. (1990). An outer membrane protein characteristic of mucoid strains of Pseudomonas aeruginosa. FEMS Microbiol Lett 56, 83-87.
19. E). Proc Natl Acad Sci USA 92, 7941-7945.
20. Hilman, B. C. (1997). Genetic and immunologic aspects of cystic fibrosis. Ann Allergy Asthma Immunol 79, 379-390.
21. Høiby, N. (1975). Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases. Acta Pathol Microbiol Scand Suppl 83, 549-552.
22. Høiby, N., Flensborg, E. W., Beck, B., Friis, B., Jacobsen, L. & Jacobsen, S. V. (1977). Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Scand J Resp Dis 58, 65-79.
23. Høiby, N., Giwercman, B., Jensen, T., Johansen, H. K., Kronborg, G., Pressler, T. & Kharazmi, A. (1993). Immune response in cystic fibrosis - helpful or harmful? In Clinical Ecology of Cystic Fibrosis, pp. 133-141. Edited by H. Scobar & others. Amsterdam: Excerpta Medica.
24. Holloway, B. W. & Morgan, A. F. (1986). Genome organization in Pseudomonas. Annu Rev Microbiol 40, 79-105.
25. Hull, J., Vervaart P., Grimwood, K. & Phelan, P. (1997). Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 52, 557-560.
26. Jensen, E. T., Kharazmi, A., Lam, K., Costerton, J. W. & Høiby, N. (1990). Human polymorphonudear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun 58, 2383-2385.
27. Jensen, E. T., Kharazmi, A., Garred, P., Kronborg, G., Fomsgaard, A., Mollnes, T. E. & Høiby, N. (1993). Complement activation by Pseudomonas aeruginosa biofilms. Microb Pathog 15, 377-388.
28. Jensen, P. & Kharazmi, A. (1991). Computer-assisted image analysis assay of human neutrophil chemotaxis in vitro. J Immunol Methods 144, 43-48.
29. Kessler, E., Safrin, M., Olson, J. C. & Ohman, D. E. (1993). Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease. J Biol Chem 268, 7503-7508.
30. Kharazmi, A. (1989). Interactions of Pseudomonas aeruginosa proteases with the cells of the immune system. In Basic and Clinical Aspects of Pseudomonas aeruginosa: Antibiotics and Chemotherapy, pp. 42-49. Edited by N. Høiby, S. S. Pedersen, G. H. Shand, G. Döring & I. A. Holder. Basel: Karger.
31. Kharazmi, A., Schiotz, P. O., Høiby, N., Baek, L. & Döring, G. (1986). Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest 16, 143-148.
32. Knutson, C. A. & Jeanes, A. (1968). A new modification of the carbazole analysis: application to heteropolysaccharides. Anal Biochem 24, 470-481.
33. Koch, C. & Høiby, N. (1993). Pathogenesis of cystic fibrosis. Lancet 341, 1065-1069.
34. Lam, J., Chan, R., Lam, K. & Costerton, J. W. (1980). Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28, 546-556.
35. Lonetto, M. A., Brown, K. L., Rudd, K. E. & Buttner, M. J. (1994). Analysis of the Streptomyces coelicolor sigE gene reveals the existence of a subfamily of eubacterial RNA polymerase σ factors involved in the regulation of extracytoplasmic functions. Proc Natl Acad Sci USA 91, 7573-7577.
36. Martin, D. W., Schurr, M. J., Mudd, M. H., Govan, J. R., Holloway, B. W. & Deretic, V. (1993). Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci USA 90, 8377-8381.
37. E and stress response. J Bacteriol 176, 6688-6696.
38. 22 for expression of the alginate regulon in Pseudomonas aeruginosa and localization of its antagonist proteins MucA and MucB (AlgN). J Bacteriol 179, 3711-3720.
39. Morihara, K. & Homma, J. Y. (1985). Pseudomonas proteases. In Bacterial Enzymes and Virulence, pp. 41-79. Edited by I. A. Holder. Boca Raton, FL: CRC Press.
40. Ohman, D. E. & Chakrabarty, A. M. (1982). Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin. Infect Immun 37, 662-669.
41. Ohman, D. E., Cryz, S. J. & Iglewski, B. H. (1980). Isolation and characterization of a Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol 142, 836-842.
42. Pedersen, S. S. (1992). Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. Acta Pathol Microbiol Immunol Scand Suppl 28, 1-79.
43. Pedersen, S. S., Moller, H., Espersen, F., Sorensen, C. H., Jensen, T. & Høiby, N. (1992). Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis. Acta Pathol Microbiol Immunol Scand 100, 326-334.
44. Pier, G. B., Grout, M., Zaidi, T. S., Olsen, J. C., Johnson, L. G., Yankaskas, J. R. & Goldberg, J. B. (1996). Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271, 64-67.
45. Rehm, B. H., Boheim, G., Tommassen, J. & Winkler, U. K. (1994). Overexpression of algE in Escherichia coli: subcellular localization, purification, and ion channel properties. J Bacteriol 176, 5639-5647.
46. Scandalios, J. G. (editor) (1997). Oxidative Stress and the Molecular Biology of Antioxidant Defenses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
47. E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J Bacteriol 178, 4997-5004.
48. Schweizer, H. P. & Hoang, T. T. (1995). An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene 158, 15-22.
49. Sferra, T. J. & Collins, F. S. (1993). The molecular biology of cystic fibrosis. Annu Rev Med 44, 133-144.
50. Shirasu, K., Dixon, R. A. & Lamb, C. (1996). Signal transduction in plant immunity. Curr Opin Immunol 8, 3-7.
51. Smith, J. J., Travis, S. M., Greenberg, E. P. & Welsh, M. J. (1996). Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229-236.
52. 2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
53. Wolfaardt, G. M., Lawrence, J. R., Robarts, R. D., Caldwell, S. J. & Caldwell, D. E. (1994). Multicellular organization in a degradative biofilm community. Appl Environ Microbiol 60, 434-446.
54. Xie, Z. D., Hershberger, C. D., Shankar, S., Ye, R. W. & Chakrabarty, A. M. (1996). Sigma factor-anti-sigma factor interaction in alginate synthesis: inhibition of AlgT by MucA. J Bacteriol 178, 4990-4996.